CYCC icon

Cyclacel Pharmaceuticals
CYCC

Overview Fund Activity

19 hedge funds and large institutions have $1.21M invested in Cyclacel Pharmaceuticals in 2023 Q2 according to their latest regulatory filings, with 1 funds opening new positions, 1 increasing their positions, 4 reducing their positions, and 3 closing their positions.

Holders
19
Holders Change
-2
Holders Change %
-9.52%
% of All Funds
0.3%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
1
Increased
1
Reduced
4
Closed
3
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

1
Susquehanna International Group
1
Susquehanna International Group
Pennsylvania
$7.18K
2
Citadel Advisors
2
Citadel Advisors
Florida
$6.76K

Top Sellers

1
Millennium Management
1
Millennium Management
New York
$29.8K
2
SSA
2
Schonfeld Strategic Advisors
New York
$392K
3
HF
3
HRT Financial
New York
$0
4
IC
4
Ikarian Capital
Texas
$0
5
ME
5
McIlrath & Eck
Washington
$5.89K
Name Holding Trade Value Shares
Change 		Shares
Change %
Two Sigma Advisers
26
Two Sigma Advisers
New York
– -$6.79K -3 Closed
1
2